Skip to main content

Portfolio

HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.

Overview as at 31 March 2018

Currency allocation of assets

Emphasis on US dollar investments

56 340 US dollar (USD) 72 Euro (EUR) 12 Other currencies (CAD, DKK, INR, SEK) 7 British pound (GBP) 5 Swiss franc (CHF) 4 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A
Allocation of assets

Mainly invested in private companies or in companies originating
from the private companies portfolio.

62 340 Public companies 59 Private companies 22 Funds 10 Cash and cash equivalents 6 Other assets 3 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A
Development phase of portfolio companies

Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.

69 90 Products on the market 32 Phase III 23 Phase II 21 Profitable 13 Phase I 9 Preclinical 2 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A
Therapeutic area of the lead product of portfolio companies

Broadly diversified areas of activity.

79 350 Others 23 Oncology 21 Orphan diseases 19 Central nervous system 9 Medical technology / diagnostics 7 Respiratory diseases 6 Autoimmune diseases 6 Metabolic diseases 6 Infectious diseases 3 #008D6C #A1564C #89733F #87AFB1 #54465D #D4A42A #B1AB8E #255B8E #5C5A4F #323D4A